1. Home
  2. MLTX vs CNXC Comparison

MLTX vs CNXC Comparison

Compare MLTX & CNXC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MLTX
  • CNXC
  • Stock Information
  • Founded
  • MLTX 2021
  • CNXC 1991
  • Country
  • MLTX Switzerland
  • CNXC United States
  • Employees
  • MLTX N/A
  • CNXC N/A
  • Industry
  • MLTX Biotechnology: Pharmaceutical Preparations
  • CNXC Computer Software: Prepackaged Software
  • Sector
  • MLTX Health Care
  • CNXC Technology
  • Exchange
  • MLTX Nasdaq
  • CNXC Nasdaq
  • Market Cap
  • MLTX 2.8B
  • CNXC 3.0B
  • IPO Year
  • MLTX N/A
  • CNXC N/A
  • Fundamental
  • Price
  • MLTX $55.75
  • CNXC $52.32
  • Analyst Decision
  • MLTX Strong Buy
  • CNXC Buy
  • Analyst Count
  • MLTX 7
  • CNXC 4
  • Target Price
  • MLTX $74.83
  • CNXC $68.75
  • AVG Volume (30 Days)
  • MLTX 380.3K
  • CNXC 642.2K
  • Earning Date
  • MLTX 08-05-2025
  • CNXC 09-24-2025
  • Dividend Yield
  • MLTX N/A
  • CNXC 2.52%
  • EPS Growth
  • MLTX N/A
  • CNXC N/A
  • EPS
  • MLTX N/A
  • CNXC 3.65
  • Revenue
  • MLTX N/A
  • CNXC $9,625,029,000.00
  • Revenue This Year
  • MLTX N/A
  • CNXC $3.62
  • Revenue Next Year
  • MLTX N/A
  • CNXC $3.16
  • P/E Ratio
  • MLTX N/A
  • CNXC $14.45
  • Revenue Growth
  • MLTX N/A
  • CNXC 11.31
  • 52 Week Low
  • MLTX $31.42
  • CNXC $36.28
  • 52 Week High
  • MLTX $58.26
  • CNXC $76.95
  • Technical
  • Relative Strength Index (RSI)
  • MLTX 59.35
  • CNXC 48.70
  • Support Level
  • MLTX $53.29
  • CNXC $49.76
  • Resistance Level
  • MLTX $56.78
  • CNXC $52.62
  • Average True Range (ATR)
  • MLTX 2.07
  • CNXC 1.71
  • MACD
  • MLTX -0.05
  • CNXC 0.53
  • Stochastic Oscillator
  • MLTX 78.36
  • CNXC 71.96

About MLTX MoonLake Immunotherapeutics

MoonLake Immunotherapeutics is a clinical-stage biotechnology company advancing therapies to address unmet needs in inflammatory skin and joint diseases. The company is focused on the development of SLK, a novel tri-specific IL-17A and IL-17F inhibiting Nanobody that has the potential, based on response levels seen in clinical trials, to drive disease modification in dermatology and rheumatology patients.

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from Philippines.

Share on Social Networks: